These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34231242)

  • 1. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects.
    Costa-Barbosa FA; Carvalho VM; Oliveira KC; Vieira JGH; Kater CE
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):677-685. PubMed ID: 34231242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
    Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers.
    Costa-Barbosa FA; Carvalho VM; Nakamura OH; Bachega TA; Vieira JG; Kater CE
    J Endocrinol Invest; 2011 Sep; 34(8):587-92. PubMed ID: 20924223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
    Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
    Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.
    Bidet M; Bellanné-Chantelot C; Galand-Portier MB; Tardy V; Billaud L; Laborde K; Coussieu C; Morel Y; Vaury C; Golmard JL; Claustre A; Mornet E; Chakhtoura Z; Mowszowicz I; Bachelot A; Touraine P; Kuttenn F
    J Clin Endocrinol Metab; 2009 May; 94(5):1570-8. PubMed ID: 19208730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.
    Turcu AF; Rege J; Chomic R; Liu J; Nishimoto HK; Else T; Moraitis AG; Palapattu GS; Rainey WE; Auchus RJ
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2283-90. PubMed ID: 25850025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
    Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K; Tsuji-Hosokawa A; Hashimoto A; Konishi K; Ishige N; Yajima H; Sutani A; Nakatani H; Gau M; Takasawa K; Tajima T; Hasegawa T; Morio T; Kashimada K
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3341-3352. PubMed ID: 36071550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 21-hydroxylase deficiency transiently mimicking combined 21- and 11beta-hydroxylase deficiency.
    Tonetto-Fernandes V; Lemos-Marini SH; De Mello MP; Ribeiro-Neto LM; Kater CE
    J Pediatr Endocrinol Metab; 2008 May; 21(5):487-94. PubMed ID: 18655532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
    Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
    Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
    Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry.
    Ueland GÅ; Dahl SR; Methlie P; Hessen S; Husebye ES; Thorsby PM
    Fertil Steril; 2022 Aug; 118(2):384-391. PubMed ID: 35725670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 21-deoxycortisone: a sensitive additive tool in 21-hydroxylase deficiency in newborns.
    Fiet J; Bachelot G; Sow C; Farabos D; Helin N; Eguether T; Dufourg MN; Bellanne-Chantelot C; Ribaut B; Bachelot A; Young J; Houang M; Lamazière A
    Eur J Endocrinol; 2024 Aug; 191(2):204-210. PubMed ID: 39137138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding genetic spectrum and discriminatory role of steroid profiling by LC-MS/MS in 11β-hydroxylase deficiency.
    Karlekar MP; Sarathi V; Lila A; Rai K; Arya S; Bhandare VV; Atluri S; Patil V; Ramteke-Jadhav S; Shah NS; Kunwar A; Bandgar T
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):533-543. PubMed ID: 33275286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between accumulated 21-deoxysteroids and mineralocorticoid signaling in 21-hydroxylase deficiency.
    Travers S; Bouvattier C; Fagart J; Martinerie L; Viengchareun S; Pussard E; Lombès M
    Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E102-E110. PubMed ID: 31821037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
    Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.